ICON shares experienced a significant decline in premarket trading following the company's announcement that it might have overstated some of its previous revenue figures. Bloomberg posted on X, highlighting that the health care services contractor has also withdrawn its financial guidance for the year. This development has raised concerns among investors and analysts, leading to increased scrutiny of ICON's financial practices. The company's decision to retract its guidance suggests potential challenges in accurately forecasting its financial performance. As the situation unfolds, stakeholders are closely monitoring any further updates from ICON regarding its revenue reporting and future projections.